
This study examined the in vitro effects of the bile duct cancer drug PRIMA-1MET on cholangiocarcinoma (CCA) cell growth to determine its potential usefulness in CCA therapy.The effect of this drug on the expression of senescent markers (p16INK4A and p21) and the phosphorylation of p53 was investigated, as was the association between senescent markers and the patients' clinicopathological data.PRIMA-1MET inhibited CCA cell growth with the half maximal-inhibitory concentration (IC50) values of 21.9-40.8 μM. PRIMA-1MET induced phospho-p53, p16INK4A and p21 triggering cellular senescence and apoptosis. High expressions of p16INK4A and p21 were associated with a high survival rate of patients with CCA.PRIMA-1MET may potentially be an alternative anticancer agent that might lead to a better prognosis in patients with CCA.
Cholangiocarcinoma, Gene Expression Regulation, Neoplastic, Quinuclidines, Bile Duct Neoplasms, Cell Line, Tumor, Humans, Apoptosis, Cellular Senescence, Neoplasm Proteins
Cholangiocarcinoma, Gene Expression Regulation, Neoplastic, Quinuclidines, Bile Duct Neoplasms, Cell Line, Tumor, Humans, Apoptosis, Cellular Senescence, Neoplasm Proteins
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
